Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study (Q33419056)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study |
scientific article |
Statements
1 reference
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study (English)
1 reference
Sagar Lonial
1 reference
Ruben Niesvizky
1 reference
Paul G Richardson
1 reference
Shaji K Kumar
1 reference
Jesus G Berdeja
1 reference
Jacob P Laubach
1 reference
Mehdi Hamadani
1 reference
A Keith Stewart
1 reference
Vivek Roy
1 reference
Robert Vescio
1 reference
Jonathan L Kaufman
1 reference
Deborah Berg
1 reference
Eileen Liao
1 reference
Alessandra Di Bacco
1 reference
Jose Estevam
1 reference
Neeraj Gupta
1 reference
Ai-Min Hui
1 reference
Vincent Rajkumar
1 reference
14 November 2014
1 reference
1 reference
15
1 reference
13
1 reference
1503-1512
1 reference
Identifiers
1 reference
1 reference